Cargando…
Novel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization and in vitro evaluation
BACKGROUND: siRNAs have a high potential for silencing critical molecular pathways that are pathogenic. Nevertheless, their clinical application has been limited by a lack of effective and safe nanotechnology-based delivery system that allows a controlled and safe transfection to cytosol of targeted...
Autores principales: | Dim, Nneka, Perepelyuk, Maryna, Gomes, Olukayode, Thangavel, Chellappagounder, Liu, Yi, Den, Robert, Lakshmikuttyamma, Ashakumary, Shoyele, Sunday A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583992/ https://www.ncbi.nlm.nih.gov/pubmed/26410728 http://dx.doi.org/10.1186/s12951-015-0124-2 |
Ejemplares similares
-
Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins
por: Perepelyuk, Maryna, et al.
Publicado: (2016) -
Biodistribution and Pharmacokinetics Study of siRNA-loaded Anti-NTSR1-mAb-functionalized Novel Hybrid Nanoparticles in a Metastatic Orthotopic Murine Lung Cancer Model
por: Perepelyuk, Maryna, et al.
Publicado: (2016) -
siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
por: Perepelyuk, Maryna, et al.
Publicado: (2017) -
Bone Health Management in the Continuum of Prostate Cancer Disease
por: Boopathi, Ettickan, et al.
Publicado: (2022) -
Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates
por: Sacko, Koita, et al.
Publicado: (2019)